Zhu, L. and so on. Characterization of intestine microbiomes in sufferers with nonalcoholic steatohepatitis (NASH): relationship between endogenous alcohol and NASH. hepatology 57601–609 (2013).
Yuan, J. and so on. Fatty liver disease is attributable to extreme manufacturing of alcohol Klebsiella pneumoniae. Cell Metab. 30675–688 (2019).
Yunossi, Z. and so on. Global views on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. hepatology https://doi.org/10.1002/hep.30251 (2018).
Farrell, GC & Larter, CZ Non-alcoholic fatty liver disease: from steatosis to cirrhosis. hepatology 43S99–S112 (2006).
Sym, WK, Teaberry, V., Choi, SS & Diehl, AM Similarities and variations in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis. 29200–210 (2009).
Diehl, AM & Day, C. Cause, pathogenesis, and remedy of nonalcoholic steatohepatitis. N. Engl. J. Med. 3772063–2072 (2017).
Pers, M. and so on. EASLE medical follow tips: administration of alcohol-related liver disease. J. Hepatol. 69154–181 (2018).
Engstler, AJ et al. Insulin resistance alters hepatic ethanol metabolism: research in mice and youngsters with nonalcoholic fatty liver disease. intestine 651–8 (2015).
Cope, Ok., Risby, T. & Diehl, AM Increased intestinal ethanol manufacturing in overweight mice: implications for the pathogenesis of fatty liver disease. gastroenterology 1191340–1347 (2000).
de Medeiros, IC & de Lima, JG Is non-alcoholic fatty liver disease endogenous alcoholic fatty liver disease? (Mechanical speculation). Med. hypotheses 85148–152 (2015).
Simic, M., Ajdukovic, N., Veselinovic, I., Mitrovic, M. & Djurendic-Brenesel, M. Endogenous ethanol manufacturing in diabetic sufferers as a medicolegal drawback. Forensic science. Int. 21697–100 (2012).
Jeon, S. & Carr, R. Effects of alcohol on hepatic lipid metabolism. J. Lipid Res. 61470–479 (2020).
Cederbaum, AI Alcohol metabolism. Clinic Liver Dis. 16667 (2012).
Wilson, DF & Matschinsky, FM Ethanol metabolism: the nice, the dangerous and the ugly. Med. hypotheses 140109638 (2020).
van Olden, C. et al. A methods biology strategy to understanding intestine microbiota and host metabolism in morbid weight problems: design of the BARIA Longitudinal Cohort Study. Journal of Internal Medicine be a part of.13157 https://doi.org/10.1111/be a part of.13157 (2020).
Nasimbeni, F et al. Clinical validation of the FLIP algorithm and SAF rating in sufferers with nonalcoholic fatty liver disease. J. Hepatol. https://doi.org/10.1016/j.jhep.2019.12.008 (2020).
Mardinoglu, A. A complete understanding of the speedy metabolic advantages of a carbohydrate-restricted weight loss plan on hepatic steatosis in people. Cell Metab. 271547–1558 (2018).
Francque, SM et al. A randomized, managed trial of the pan-PPAR agonist lanifibranor in NASH. N. Engl. J. Med. 3851547–1558 (2021).
Elshagebee, F. Ethanol manufacturing by chosen intestine microorganisms and lactic acid micro organism grown beneath completely different dietary situations. Front Microbiol. 747 (2016).
Pyo, JH et al. Proton pump inhibitor use and danger of fatty liver disease: a nationwide cohort examine. J. Gastroenterol. Hepatol. 361235–1243 (2021).
Krautkramer, KA, Fan, J. & Bäckhed, F. Gut microbial metabolites as mediators of multi-kingdom. nat. Rev. Microbiol. 1977–94 (2020).
Fell, JC & Scherer, M. Evaluating the potential effectiveness of reducing the blood alcohol focus (BAC) for driving in the US from 0.08 to 0.05 grams. Alcohol. Clinic Exp. Res. 412128–2139 (2017).
Nosova, T. Aldehyde dehydrogenase exercise and acetate manufacturing by cardio micro organism representing the traditional flora of the human colon. Alcohol Alcohol. 31555-564 (1996).
Frantz, JC & McCallum, RE Growth yield and fermentation steadiness Bacteroides fragilis Grown in medium enriched with glucose. J. Bacteriol. 1371263–1270 (1979).
Amaretti, A. et al. Kinetics and metabolism Bifidobacterium adolescentis MB 239 grows on glucose, galactose, lactose and galactooligosaccharides. Application. Environ. Microbiol. 733637–3644 (2007).
Weimer, PJ & Zeikus, JG Fermentation of cellulose and cellobiose Clostridium thermocellum in the absence and presence Methanobacteria are thermoautotrophic. Application. Environ. Microbiol. 33289-297 (1977).
del Chierico, F. et al. Gut microbiota profiling in pediatric nonalcoholic fatty liver disease and weight problems sufferers revealed by an built-in meta-omics-based strategy. hepatology 65451–464 (2017).
Deshaso, M. and so on. Characterization of intestine microbiota composition in populations of various ethnicity however widespread geography. nat. Med. 241526–1531 (2018).
Al, Y. et al. Regional variation limits using wholesome intestine microbiome reference ranges and disease fashions. nat. Med. 241532–1535 (2018).
Fuchs, HF et al. The advantages of bariatric surgical procedure don’t lengthen to overweight males. J. Laparoendosc. Adv. Surg. Tech. THE 25196–201 (2015).
Seitz, HK et al. Alcoholic liver disease. nat. Rev. Dis. the primary 416 (2018).
Meijnikman, AS et al. Differences in intestine microbial composition and useful capability from lean to overweight topics. J. Med. https://doi.org/10.1111/be a part of.13137 (2020).
Kleiner, DE et al. Development and validation of a histologic scoring system for nonalcoholic fatty liver disease. hepatology https://doi.org/10.1002/hep.20701 (2005).
Bedosa, P. & FLIP Pathology Consortium Utility and Appropriateness of the Fatty Liver Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) in Nonalcoholic Fatty Liver Disease Biopsies Evaluation.hepatology 60565–575 (2014).
Costea, PI et al. Towards requirements for human faecal pattern processing in metagenomic research. nat. Biotechnology. https://doi.org/10.1038/nbt.3960 (2017).
Karlsson, FH, Nookaew, I. & Nielsen, J. Metagenomic information utilization and evaluation (MEDUSA) and building of a world intestine microbial gene catalog. PLoS Comput. Biol. 10e1003706 (2014).
Langmead, B. & Salzberg, SL Rapid distance-reading alignment with Bowtie 2. nat. Methods https://doi.org/10.1038/nmeth.1923 (2012).
Chamberlain, SA & Szöcs, E. taxize: taxonomic search and retrieval in R. F1000Res 2, 191 (2013).
Soverini, M. and so on. HumanMycobiomeScan: a brand new bioinformatics instrument for fungal fraction characterization in metagenomic samples. BMC Genomics 20496 (2019).
Edgar, RC. The search and clustering routine is quicker than BLAST. bioinformatics 262460–2461 (2010).
Edgar, RC UNOISE2: error correction for Illumina 16S and ITS amplicon sequencing. on preprint bioRxiv 081257 https://doi.org/10.1101/081257 (2016).
Wang, Q., Garrity, GM, Tiedje, JM & Cole, JR Naive Bayesian classifier for speedy task of rRNA sequences to new bacterial taxonomy. Application. Environ. Microbiol. 735261–5267 (2007).
Quast, C. et al. The SILVA ribosomal RNA gene database challenge: improved information processing and web-based instruments. Nucleic Acids Res. 41D590–D596 (2013).
Bolger, AM, Lohse, M. & Usadel, B. Trimmomatic: a versatile trimmer for Illumina sequence information. bioinformatics 302114–2120 (2014).
Bray, NL, Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. nat. Biotechnology. 34525–527 (2016).
R Basic command. A: A language and setting for statistical computing. (R Foundation for Statistical Computing, 2013).
Love, MI, Huber, W. & Anders, S. Moderated estimation of fold change and variance for RNA-seq information with DESeq2. Genome Biol. 15550 (2014).
Oksanen, J. The bundle is “vegetarian”. Community Environment Package. (2019).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery charge: a sensible and strong strategy to a number of testing. J. Roy. Stat. social B 57289–300 (1995).